Using Ocrevus (ocrelizumab) as a first-line treatment for early-stage relapsing forms of multiple sclerosis (MS) is significantly better at delaying disease progression than starting with a less effe… [+5146 chars]
First-line Ocrevus may aid early relapsing MS long-term outcomes - Multiple Sclerosis News Today
Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less effective drug.
By:Andrea Lobo, PhD
Source:Multiple Sclerosis News Today
Published:
Related News
A Single Molecule May Explain How Blood Flow in The Brain Triggers Dementia - ScienceAlert
Reduced blood flow to the brain is thought to be a key factor in many forms of dementia, including Alzheimer's, and scientists have just identified a new mechanism regulating this flow, which may also help explain how it goes wrong.
ScienceAlert•David Nield
Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says - statnews.com
Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study found.
STAT•Elizabeth Cooney
21 year old Rigby man who had a 'heart of gold' continues to bless others after unexpected death - East Idaho News
RIGBY — A Rigby man, remembered for the selfless life he lived, was able to bless others through organ donation. Noel Rios, who went by the name Titus Freeman, died on the evening of Oct. 19, 2025, at the age of 21. He was riding his dirt bike — he’s been rid…
East Idaho News•Brittni Johnson